FibroDynamx

FibroDynamx is a drug discovery company developing therapies that promote tissue regeneration, without scarring. The platform is based on their Regenerative Blueprint, which combines proprietary data from their reindeer model with human wound healing data. Their first product (FD-001, a protein-based drug) prevents scar formation, and improves skin regeneration 10-fold in animal models of skin injury.